Saturn V Capital Management’s Alto Neuroscience ANRO Stock Holding History

Saturn V Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.82M	Buy	182,829 +93,830	+105%	+$2.17M	0.69%	21
2026 Q1	$2M	Buy	+88,999	New	+$1.65M	0.36%	20

Other funds holding ANRO

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSC

Spruce Street Capital New York $510M AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Saturn V Capital Management's ANRO Position: Q2 2026 in Review

Saturn V Capital Management increased its Alto Neuroscience (ANRO) stake by 105% in Q2 2026, buying an estimated $2.17M and bringing the position to 182,829 shares worth $4.82M. The position accounts for 0.69% of the portfolio, ranked #21.

Saturn V Capital Management first reported a position in ANRO in Q1 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

Saturn V Capital Management held 182,829 shares of Alto Neuroscience worth $4.82M as of Q2 2026.
Saturn V Capital Management bought 93,830 Alto Neuroscience shares in Q2 2026, an estimated $2.17M.
Alto Neuroscience made up 0.69% of Saturn V Capital Management's portfolio in Q2 2026, its #21 holding.
Saturn V Capital Management first reported a position in Alto Neuroscience in Q1 2026 and has held it in 2 quarters since.
114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Saturn V Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.